|
1
|
Brown RA, Fernandez-Pol S and Kim J:
Primary cutaneous anaplastic large cell lymphoma. J Cutan Pathol.
44:570–577. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sarfraz H, Gentille C, Ensor J, Wang L,
Wong S, Ketcham MS, Joshi J and Pingali SRK: Primary cutaneous
anaplastic large-cell lymphoma: A review of the SEER database from
2005 to 2016. Clin Exp Dermatol. 46:1420–1426. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Istiadi H, Sadhana U, Puspasari D, Miranti
IP, Karlowee V, Listiana DE and Prasetyo A: Role of cell-origin
profiling using immunohistochemistry to predict the survival of
patients with diffuse large B-cell lymphoma in Indonesia. Yonago
Acta Med. 64:200–206. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Savage KJ, Harris NL, Vose JM, Ullrich F,
Jaffe ES, Connors JM, Rimsza L, Pileri SA, Chhanabhai M, Gascoyne
RD, et al: ALK-anaplastic large-cell lymphoma is clinically and
immunophenotypically different from both ALK+ ALCL and peripheral
T-cell lymphoma, not otherwise specified: Report from the
international peripheral T-cell lymphoma project. Blood.
111:5496–5504. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Oschlies I, Lisfeld J, Lamant L, Nakazawa
A, d'Amore ES, Hansson U, Hebeda K, Simonitsch-Klupp I, Maldyk J,
Müllauer L, et al: ALK-positive anaplastic large cell lymphoma
limited to the skin: Clinical, histopathological and molecular
analysis of 6 pediatric cases. A report from the ALCL99 study.
Haematologica. 98:50–56. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
ten Berge RL, Snijdewint FG, von
Mensdorff-Pouilly S, Poort-Keesom RJ, Oudejans JJ, Meijer JW,
Willemze R, Hilgers J and Meijer CJ: MUC1 (EMA) is preferentially
expressed by ALK positive anaplastic large cell lymphoma, in the
normally glycosylated or only partly hypoglycosylated form. J Clin
Pathol. 54:933–939. 2001.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shustov A and Soma L: Anaplastic large
cell lymphoma: Contemporary concepts and optimal management. Cancer
Treat Res. 176:127–144. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Leventaki V, Bhattacharyya S and Lim MS:
Pathology and genetics of anaplastic large cell lymphoma. Semin
Diagn Path. 37:57–71. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hare L, Burke GAA and Turner SD:
Resistance to targeted agents used to treat paediatric ALK-positive
ALCL. Cancers (Basel). 13(6003)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen H, Xiong JS, Sheng N, Zong WK, Wang
YH, Li M and Sun JF: Primary cutaneous sarcomatoid anaplastic
lymphoma kinase-positive anaplastic large-cell lymphoma with linear
distributional lesions. Am J Dermatopathol. 39:863–866.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sasaki K, Sugaya M, Fujita H, Takeuchi K,
Torii H, Asahina A and Tamaki K: A case of primary cutaneous
anaplastic large cell lymphoma with variant anaplastic lymphoma
kinase translocation. Br J Dermatol. 150:1202–1207. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hosoi M, Ichikawa M, Imai Y and Kurokawa
M: A case of anaplastic large cell lymphoma, ALK positive, primary
presented in the skin and relapsed with systemic involvement and
leukocytosis after years of follow-up period. Int J Hematol.
92:667–668. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Aoki M, Niimi Y, Takezaki S, Azuma A,
Seike M and Kawana S: CD30+ lymphoproliferative disorder: Primary
cutaneous anaplastic large cell lymphoma followed by lymphomatoid
papulosis. Br J Dermatol. 145:123–126. 2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kato N, Mizuno O, Ito K, Kimura K and
Shibata M: Neutrophil-rich anaplastic large cell lymphoma
presenting in the skin. Am J Dermatopathol. 25:142–147.
2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Melchers RC, Willemze R, van de Loo M, van
Doorn R, Jansen PM, Cleven AHG, Solleveld N, Bekkenk MW, van Kester
MS, Diercks GFH, et al: Clinical, histologic, and molecular
characteristics of anaplastic lymphoma kinase-positive primary
cutaneous anaplastic large cell lymphoma. Am J Surg Pathol.
44:776–781. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chao-Lo MP, King-Ismael D and Lopez RA:
Primary cutaneous CD30+ anaplastic large cell lymphoma: Report of a
rare case. J Dermatol Case Rep. 2:31–34. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Su LD, Schnitzer B, Ross CW, Vasef M, Mori
S, Shiota M, Mason DY, Pulford K, Headington JT and Singleton TP:
The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and
cutaneous CD30+ lymphoproliferative disorders. J Cutan Pathol.
24:597–603. 1997.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xue D, Li X, Ren Y, Liu Q, Yen Y and Xue
L: Primary cutaneous anaplastic large cell lymphoma with positive
ALK expression and a rapidly progressive cutaneous nodule. Int J
Surg Pathol. 23:333–335. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Quintanilla-Martinez L, Jansen PM, Kinney
MC, Swerdlow SH and Willemze R: Non-mycosis fungoides cutaneous
T-cell lymphomas: Report of the 2011 society for
hematopathology/european association for haematopathology workshop.
Am J Clin Pathol. 139:491–514. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kadin ME, Pinkus JL, Pinkus GS, Duran IH,
Fuller CE, Onciu M, Kawaguchi H and Morris SW: Primary cutaneous
ALCL with phosphorylated/activated cytoplasmic ALK and novel
phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative. Am J
Surg Pathol. 32:1421–1426. 2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Geller S, Canavan TN, Pulitzer M,
Moskowitz AJ and Myskowski PL: ALK-positive primary cutaneous
anaplastic large cell lymphoma: A case report and review of the
literature. Int J Dermatol. 57:515–520. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kumaran MS, Jithendriya M, Nagaraj P,
Tirumalae R and Jayaseelan E: Anaplastic lymphoma kinase-positive
primary cutaneous anaplastic large cell lymphoma-is it a new
variant? Indian J Dermatol Venereol Leprol. 78:354–357.
2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Campo E, Chott A, Kinney MC, Leoncini L,
Meijer CJ, Papadimitriou CS, Piris MA, Stein H and Swerdlow SH:
Update on extranodal lymphomas. Conclusions of the workshop held by
the EAHP and the SH in Thessaloniki, Greece. Histopathology.
48:481–504. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Barbé J, Escobar G, Marzouki-Zerouali A,
Lardenois E, Schmutz JL and Bursztejn AC: Disseminated indolent
ALK-positive primary cutaneous anaplastic large cell lymphoma
(C-ALCL) lasting for 10 years. Int J Dermatol. 60:e146–e147.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tokuyama M, Kurashige Y, Ota T, Manabe Y,
Yamaoka H, Ikoma N, Fukumura A, Miyashita M, Otsubo K, Morimoto T,
et al: Pediatric case of anaplastic lymphoma kinase-positive
anaplastic large cell lymphoma forming a solitary skin tumor on the
forearm. J Dermatol. 44:465–467. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pulitzer M, Ogunrinade O, Lin O and
Steinherz P: ALK-positive (2p23 rearranged) anaplastic large cell
lymphoma with localization to the skin in a pediatric patient. J
Cutan Pathol. 42:182–187. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hinshaw M, Trowers AB, Kodish E, Kuerbitz
S, Shurin S and Wood GS: Three children with CD30+ cutaneous
anaplastic large cell lymphomas bearing the t(2;5)(p23;q35)
translocation. Pediatr Dermatol. 21:212–217. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tamiolakis D, Papadopoulos N, Venizelos J,
Kakagia D, Nikolaidou S, Bolioti S and Kouskoukis C: ALK-positive
neutrophil-rich variant of anaplastic large cell lymphoma diagnosed
after head trauma. Onkologie. 28:356–358. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kempf W, Pfaltz K, Vermeer MH, Cozzio A,
Ortiz-Romero PL, Bagot M, Olsen E, Kim YH, Dummer R, Pimpinelli N,
et al: EORTC, ISCL, and USCLC consensus recommendations for the
treatment of primary cutaneous CD30-positive lymphoproliferative
disorders: Lymphomatoid papulosis and primary cutaneous anaplastic
large-cell lymphoma. Blood. 118:4024–4035. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Delsol G, Gatter KC, Stein H, Erber WN,
Pulford KA, Zinne K and Mason DY: Human lymphoid cells express
epithelial membrane antigen. Implications for diagnosis of human
neoplasms. Lancet. 2:1124–1129. 1984.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Delsol G, Al Saati T, Gatter KC, Gerdes J,
Schwarting R, Caveriviere P, Rigal-Huguet F, Robert A, Stein H and
Mason DY: Coexpression of epithelial membrane antigen (EMA), Ki-1,
and interleu-kin-2 receptor by anaplastic large cell lymphoma.
Diagnostic value in so-called malignant histiocytosis. Am J Pathol.
130:59–70. 1988.PubMed/NCBI
|
|
32
|
Benharroch D, Meguerian-Bedoyan Z, Lamant
L, Amin C, Brugières L, Terrier-Lacombe MJ, Haralambieva E, Pulford
K, Pileri S, Morris SW, et al: ALK-positive lymphoma: A single
disease with a broad spectrum of morphology. Blood. 91:2076–2084.
1998.PubMed/NCBI
|
|
33
|
National Comrehensive Cancer Network:
Primary Cutaneous Lymphoma (Version 2.2022). NCCN, Plymouth
Meeting, PA, 2022. https://www.nccn.org/professionals/physician_gls/pdf/primary_cutaneous.pdf.
Accessed September 12, 2022.
|
